Radio wave electrotherapy with a radiofrequency of 448 khz for the treatment of patients with organic erectile dysfunction: a prospective, randomized, blind, Sham-controlled, parallel-group study
- Authors: Chuvalov L.L1, Korolev D.O1, Azilgareeva C.R1, Taratkin M.S1, Olefir Y.V1, Fiev D.N1, Lumpov I.S1, Gorobets Y.P1, Enikeev D.V1, Rapoport L.M1, Enikeev M.E1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: No 2 (2022)
- Pages: 54-58
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/312845
- DOI: https://doi.org/10.18565/urology.2022.2.54-58
- ID: 312845
Cite item
Abstract
Full Text
About the authors
L. L Chuvalov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: chuvalovleo386@mail.ru
urologist, PhD student, Institute for Urology and Reproductive Health
D. O Korolev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: korolevdmitryo@gmail.com
Candidate of Medical Sciences, Senior Researcher, Institute for Urology and Reproductive Health
C. R Azilgareeva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: camilla.azilgareeva@yandex.ru
student, International School «Medicine of the Future»
M. S Taratkin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: marktaratkin@gmail.com
urologist, researcher, Institute for Urology and Reproductive Health
Y. V Olefir
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: olefir_yu_v@staff.sechenov.ru
Doctor of Medical Sciences, Professor, Institute for Urology and Reproductive Health
D. N Fiev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: fiev@mail.ru
Urologist, Doctor of Medical Sciences, Institute for Urology and Reproductive Health
I. S Lumpov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: urology27@mail.ru
urologist, Institute for Urology and Reproductive Health
Y. P Gorobets
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: gorobets9@yandex.ru
resident, Institute for Urology and Reproductive Health
D. V Enikeev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: enikmic@mail.ru
Doctor of Medical Sciences, Professor, Head of the International Department, Institute for Urology and Reproductive Health
L. M Rapoport
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: leonidrapoport@yandex.ru
Doctor of Medical Sciences, Professor, Deputy Director, Institute for Urology and Reproductive Health
M. E Enikeev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: enikmic@mail.ru
Doctor of Medical Sciences, Professor, Head of the Urological Department №2, Institute for Urology and Reproductive Health
References
- Marumo K., Murai M. Aging and erectile dysfunction: The role of ageing and concomitant chronic illness.Int J Urol. 2001;8(8):S50-557.
- Shamloul R., Ghanem H. Erectile dysfunction. The Lancet. 2013;381:153-165.
- Cao S., Yin X., Wang Y, Zhou H., Song F, Lu Z. Smoking and Risk of Erectile Dysfunction: Systematic Review of Observational Studies with Meta-Analysis. PLoS One. 2013;8(4).
- Calogero A.E., Burgio G., Condorelli R.A., Cannarella R., La Vignera S. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male. 2019;22:12-19.
- Salonia A., Bettocchi C., Boeri L., Capogrosso P., Carvalho J., Cilesiz N.C., et al. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction [Internet]. European Urology. Elsevier; 2021;80:333-357. [cited 2021 Nov 17]. Available from: http://www.europeanurology.com/article/S0302283821018133/fulltext
- Ventimiglia E., Capogrosso P., Montorsi F., Salonia A. The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opinion on Drug Safety. 2016;15:141-152.
- Michl U., Molfenter F., Graefen M., Tennstedt P., Ahyai S., Beyer B., et al. Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy. J Urol. 2015;193(2):479-483.
- Li W.Q., Qureshi A.A., Robinson K.C., Han J. Sildenafil use and increased risk of incident melanoma in US men: A prospective cohort study. JAMA Intern Med. 2014;174(6):964-970.
- Salonia A., Bettocchi C., Carvalho J., Corona G., Jones T.H., Kadioglu A., et al. Sexual and Reproductive Health EAU Guidelines [Internet]. 2021. 282 p. Available from: https://uroweb.org/guideline/sexual-and-reproductive-health/#10
- Kumaran B., Watson T. Skin thermophysiological effects of 448 kHz capacitive resistive monopolar radiofrequency in healthy adults: A randomised crossover study and comparison with pulsed shortwave therapy. Electromagn Biol Med. 2018;37(1):1-12.
- Hernandez-Bule M.L., Marti'nez-Botas J., Trillo M.A., Pai'no C.L., Ubeda A. Antiadipogenic effects of subthermal electric stimulation at 448 kHz on differentiating human mesenchymal stem cells. Mol Med Rep. 2016;13(5):3895-903.
- Heinonen I., Bucci M., Kemppainen J., Knuuti J., Nuutila P., Boushel R., et al. Regulation of subcutaneous adipose tissue blood flow during exercise in humans. J Appl Physiol. 2012;112(6):1059-1063.